Correction: Mouse Models of Diet-Induced Nonalcoholic Steatohepatitis Reproduce the Heterogeneity of the Human Disease

1 Division of Gastroenterology, Department of Medicine, Duke University Medical Center, Durham, NC 27710, United States of America, 2 Gastroenterology Department, Hospital de Santa Maria, CHLN, Lisbon, Portugal, 3 Division of Endocrinology, Duke University Medical Center, Durham, NC 27710, United States of America, 4 Division of Pathology, Duke University Medical Center, Durham, NC 27710, United States of America

[1]  A. Diehl,et al.  Mouse Models of Diet-Induced Nonalcoholic Steatohepatitis Reproduce the Heterogeneity of the Human Disease , 2015, PloS one.

[2]  Mats Fredrikson,et al.  Fibrosis stage is the strongest predictor for disease‐specific mortality in NAFLD after up to 33 years of follow‐up , 2015, Hepatology.

[3]  Zhen Wang,et al.  Fibrosis progression in nonalcoholic fatty liver vs nonalcoholic steatohepatitis: a systematic review and meta-analysis of paired-biopsy studies. , 2015, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[4]  G. Gores,et al.  Ballooned hepatocytes, undead cells, sonic hedgehog, and Vitamin E: Therapeutic implications for nonalcoholic steatohepatitis , 2015, Hepatology.

[5]  H. Cortez‐Pinto,et al.  Non-alcoholic fatty liver disease: what the clinician needs to know. , 2014, World journal of gastroenterology.

[6]  Jung-jae Kim,et al.  Pharmacological correction of obesity-induced autophagy arrest using calcium channel blockers , 2014, Nature Communications.

[7]  G. Karaca,et al.  Reduced lipoapoptosis, hedgehog pathway activation and fibrosis in caspase-2 deficient mice with non-alcoholic steatohepatitis , 2014, Gut.

[8]  M. Trauner,et al.  Role of adipose tissue in methionine–choline-deficient model of non-alcoholic steatohepatitis (NASH)☆ , 2014, Biochimica et biophysica acta.

[9]  Ken-ichi Yoshida,et al.  Immunohistochemical study of the autophagy marker microtubule‐associated protein 1 light chain 3 in normal and steatotic human livers , 2014, Hepatology research : the official journal of the Japan Society of Hepatology.

[10]  Aijaz Ahmed,et al.  Nonalcoholic steatohepatitis is the most rapidly growing indication for liver transplantation in patients with hepatocellular carcinoma in the U.S. , 2014, Hepatology.

[11]  Á. Valverde,et al.  Impaired autophagic flux is associated with increased endoplasmic reticulum stress during the development of NAFLD , 2014, Cell Death and Disease.

[12]  C. DiDonato,et al.  Dissociation of hepatic insulin resistance from susceptibility of nonalcoholic fatty liver disease induced by a high-fat and high-carbohydrate diet in mice. , 2014, American journal of physiology. Gastrointestinal and liver physiology.

[13]  K. Ogawa,et al.  Morphological and functional characterization of non-alcoholic fatty liver disease induced by a methionine-choline-deficient diet in C57BL/6 mice. , 2013, International journal of clinical and experimental pathology.

[14]  Rohit Loomba,et al.  The global NAFLD epidemic , 2013, Nature Reviews Gastroenterology &Hepatology.

[15]  S. Murphy,et al.  Relationship between methylome and transcriptome in patients with nonalcoholic fatty liver disease. , 2013, Gastroenterology.

[16]  R. Green,et al.  The Unfolded Protein Response in Fatty Liver Disease , 2013, Seminars in Liver Disease.

[17]  F. Lammert,et al.  PNPLA3-Associated Steatohepatitis: Toward a Gene-Based Classification of Fatty Liver Disease , 2013, Seminars in Liver Disease.

[18]  S. Akyol,et al.  The relationship between oxidative stress and nonalcoholic fatty liver disease: Its effects on the development of nonalcoholic steatohepatitis , 2013, Redox report : communications in free radical research.

[19]  G. Karaca,et al.  Smoothened is a master regulator of adult liver repair. , 2013, The Journal of clinical investigation.

[20]  D. Fair,et al.  Fructose ingestion and cerebral, metabolic, and satiety responses. , 2013, JAMA.

[21]  Caroline L. Wilson,et al.  Multigenerational Epigenetic Adaptation of the Hepatic Wound-Healing Response , 2012, Nature Medicine.

[22]  A. Suzuki,et al.  Hedgehog pathway activation parallels histologic severity of injury and fibrosis in human nonalcoholic fatty liver disease , 2012, Hepatology.

[23]  G. Gores,et al.  Mechanisms of Lipotoxicity in NAFLD and Clinical Implications , 2011, Journal of pediatric gastroenterology and nutrition.

[24]  S. Hazen,et al.  OxNASH Score Correlates with Histologic Features and Severity of Nonalcoholic Fatty Liver Disease , 2011, Digestive Diseases and Sciences.

[25]  D. Mikhailidis,et al.  Safety and efficacy of long-term statin treatment for cardiovascular events in patients with coronary heart disease and abnormal liver tests in the Greek Atorvastatin and Coronary Heart Disease Evaluation (GREACE) Study: a post-hoc analysis , 2010, The Lancet.

[26]  April D. Lake,et al.  Diversity in Antioxidant Response Enzymes in Progressive Stages of Human Nonalcoholic Fatty Liver Disease , 2010, Drug Metabolism and Disposition.

[27]  B. Neuschwander‐Tetri,et al.  Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis. , 2010, The New England journal of medicine.

[28]  G. Karaca,et al.  Hedgehog-mediated epithelial-to-mesenchymal transition and fibrogenic repair in nonalcoholic fatty liver disease. , 2009, Gastroenterology.

[29]  Johannes le Coutre,et al.  Fat Detection: Taste, Texture, and Post Ingestive Effects , 2009 .

[30]  M. Yeh,et al.  MCD-induced steatohepatitis is associated with hepatic adiponectin resistance and adipogenic transformation of hepatocytes. , 2008, Journal of hepatology.

[31]  M. Neuman,et al.  Methionine Deficiency and Hepatic Injury in a Dietary Steatohepatitis Model , 2008, Digestive Diseases and Sciences.

[32]  B. Copple,et al.  The Transition from Fatty Liver to NASH Associates with SAMe Depletion in db/db Mice Fed a Methionine Choline-Deficient Diet , 2008, Digestive Diseases and Sciences.

[33]  J. Sicklick,et al.  Hepatic accumulation of Hedgehog-reactive progenitors increases with severity of fatty liver damage in mice , 2007, Laboratory Investigation.

[34]  J. Sicklick,et al.  Sustained activation of Rac1 in hepatic stellate cells promotes liver injury and fibrosis in mice , 2006, Hepatology.

[35]  R. E. Pitas,et al.  Mice fed a lipogenic methionine-choline-deficient diet develop hypermetabolism coincident with hepatic suppression of SCD-1 s⃞ Published, JLR Papers in Press, July 8, 2006. , 2006, Journal of Lipid Research.

[36]  O. Cummings,et al.  Design and validation of a histological scoring system for nonalcoholic fatty liver disease , 2005, Hepatology.

[37]  M. Czaja,et al.  Hepatocyte CYP2E1 Overexpression and Steatohepatitis Lead to Impaired Hepatic Insulin Signaling* , 2005, Journal of Biological Chemistry.

[38]  T. Mak,et al.  Hepatocyte-specific Pten deficiency results in steatohepatitis and hepatocellular carcinomas. , 2004, The Journal of clinical investigation.

[39]  M. Charlton,et al.  Hepatic gene expression in histologically progressive nonalcoholic steatohepatitis , 2003, Hepatology.

[40]  F. Brancati,et al.  The prevalence and etiology of elevated aminotransferase levels in the United States , 2003, American Journal of Gastroenterology.

[41]  B. Yandell,et al.  Loss of stearoyl–CoA desaturase-1 function protects mice against adiposity , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[42]  A. Choi,et al.  Heme oxygenase-1: function, regulation, and implication of a novel stress-inducible protein in oxidant-induced lung injury. , 1996, American journal of respiratory cell and molecular biology.

[43]  April D. Lake,et al.  The adaptive endoplasmic reticulum stress response to lipotoxicity in progressive human nonalcoholic fatty liver disease. , 2014, Toxicological sciences : an official journal of the Society of Toxicology.

[44]  Simone D. Hennink,et al.  Fats and satiety , 2013 .

[45]  D. Sorescu,et al.  Glp-1 analog, liraglutide, ameliorates hepatic steatosis and cardiac hypertrophy in C57BL/6J mice fed a Western diet. , 2012, American journal of physiology. Gastrointestinal and liver physiology.

[46]  T. Luedde,et al.  Deletion of NEMO/IKKgamma in liver parenchymal cells causes steatohepatitis and hepatocellular carcinoma. , 2007, Cancer cell.

[47]  I. Leclercq,et al.  Intrahepatic insulin resistance in a murine model of steatohepatitis: effect of PPARγ agonist pioglitazone , 2007, Laboratory Investigation.